Pictet North America Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.04M | Buy |
18,299
+3,959
| +28% | +$1.1M | 0.36% | 54 |
|
|
2026
Q1 | $4.24M | Sell |
14,340
-471
| -3% | -$140K | 0.42% | 55 |
|
|
2025
Q4 | $4.04M | Sell |
14,811
-537
| -3% | -$146K | 0.38% | 58 |
|
|
2025
Q3 | $4.15M | Buy |
15,348
+329
| +2% | +$89.5K | 0.39% | 54 |
|
|
2025
Q2 | $4.14M | Sell |
15,019
-1,558
| -9% | -$424K | 0.42% | 55 |
|
|
2025
Q1 | $4.4M | Buy |
16,577
+56
| +0.3% | +$13.8K | 0.44% | 57 |
|
|
2024
Q4 | $3.84M | Buy |
16,521
+293
| +2% | +$67.4K | 0.36% | 62 |
|
|
2024
Q3 | $3.58M | Buy |
16,228
+66
| +0.4% | +$13.7K | 0.35% | 63 |
|
|
2024
Q2 | $3.18M | Sell |
16,162
-16,094
| -50% | -$3.33M | 0.35% | 65 |
|
|
2024
Q1 | $6.94M | Sell |
32,256
-4,448
| -12% | -$934K | 0.78% | 31 |
|
|
2023
Q4 | $7.73M | Sell |
36,704
-29
| -0.1% | -$6.19K | 1% | 26 |
|
|
2023
Q3 | $7.35M | Buy |
36,733
+13,902
| +61% | +$2.76M | 1.04% | 25 |
|
|
2023
Q2 | $4.23M | Buy |
22,831
+3,533
| +18% | +$653K | 0.59% | 38 |
|
|
2023
Q1 | $3.7M | Buy |
19,298
+16,123
| +508% | +$2.92M | 0.6% | 41 |
|
|
2022
Q4 | $534K | Buy |
3,175
+200
| +7% | +$34.8K | 0.09% | 100 |
|
|
2022
Q3 | $527K | Hold |
2,975
| – | – | 0.08% | 104 |
|
|
2022
Q2 | $609K | Hold |
2,975
| – | – | 0.08% | 100 |
|
|
2022
Q1 | $708K | Hold |
2,975
| – | – | 0.08% | 90 |
|
|
2021
Q4 | $680K | Hold |
2,975
| – | – | 0.07% | 92 |
|
|
2021
Q3 | $575K | Hold |
2,975
| – | – | 0.06% | 95 |
|
|
2021
Q2 | $633K | Hold |
2,975
| – | – | 0.07% | 93 |
|
|
2021
Q1 | $608K | Hold |
2,975
| – | – | 0.07% | 91 |
|
|
2020
Q4 | $542K | Hold |
2,975
| – | – | 0.07% | 100 |
|
|
2020
Q3 | $498K | Hold |
2,975
| – | – | 0.07% | 102 |
|
|
2020
Q2 | $484K | Hold |
2,975
| – | – | 0.07% | 105 |
|
|
2020
Q1 | $514K | Hold |
2,975
| – | – | 0.09% | 102 |
|
|
2019
Q4 | $597K | Hold |
2,975
| – | – | 0.07% | 108 |
|
|
2019
Q3 | $629K | Hold |
2,975
| – | – | 0.09% | 103 |
|
|
2019
Q2 | $577K | Hold |
2,975
| – | – | 0.08% | 104 |
|
|
2019
Q1 | $490K | Hold |
2,975
| – | – | 0.07% | 109 |
|
|
2018
Q4 | $560K | Hold |
2,975
| – | – | 0.05% | 108 |
|
|
2018
Q3 | $506K | Buy |
+2,975
| New | +$501K | 0.07% | 123 |
|
Other funds holding CME
Pictet North America Advisors's CME Position: Q2 2026 in Review
Pictet North America Advisors increased its CME Group (CME) stake by 28% in Q2 2026, buying an estimated $1.1M and bringing the position to 18,299 shares worth $4.04M. The position accounts for 0.36% of the portfolio, ranked #54.
Pictet North America Advisors first reported a position in CME in Q3 2018 and has held it in 32 quarters since. The position peaked at $7.73M in Q4 2023. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Pictet North America Advisors held 18,299 shares of CME Group worth $4.04M as of Q2 2026.
- Pictet North America Advisors bought 3,959 CME Group shares in Q2 2026, an estimated $1.1M.
- CME Group made up 0.36% of Pictet North America Advisors's portfolio in Q2 2026, its #54 holding.
- Pictet North America Advisors first reported a position in CME Group in Q3 2018 and has held it in 32 quarters since.
- Pictet North America Advisors's CME Group position peaked at $7.73M in Q4 2023.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.